查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589606

濫用藥物測試市場：按成分、樣品類型和最終用戶 - 2025-2030 年全球預測

Drug of Abuse Testing Market by Component (Analyzers, Consumables, Laboratory Services), Sample Type (Blood, Hair, Oral Fluids), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年濫用藥物測試市場價值為17.4億美元，預計到2024年將達到18.7億美元，複合年成長率為7.28%，到2030年將達到28.6億美元。

濫用藥物檢測市場包括對尿液、血液、唾液和頭髮等生物樣本中非法藥物和處方藥物的分析、檢測和監測。由於全球藥物濫用問題日益嚴重，對藥物篩檢的需求不斷增加，從而支撐了職場、體育和執法環境中的公共問題和法規，從而定義了該市場。藥物濫用檢測的必要性源於其在確保合規性、促進無毒品環境和降低與藥物濫用相關的風險方面的重要作用。應用程式涵蓋各個領域，包括醫療保健、企業、教育機構、法醫學領域和復健中心。產業成長是由毒癮流行、嚴格的政府監管以及檢測方法的技術進步等因素所推動的。實驗室晶片實驗室、即時監控穿戴式裝置以及基於人工智慧的分析工具等創新為市場參與者帶來了巨大潛力。然而，隱私問題、先進藥物檢測設備的高成本以及地區監管差異等挑戰可能會阻礙成長。圍繞檢測的恥辱和潛在的誤報也是主要挑戰。對於尋求創新的公司來說，專注於開發具有成本效益、快速且微創的檢測解決方案可以帶來重大機會。使用質譜儀和生物感測器等下一代測試平台來提高準確性和周轉時間也可以為成長鋪平道路。此外，與研究機構合作開發預防藥物濫用的預測模型可以提供競爭優勢。儘管取得了這些進步，但平衡技術創新與個人資訊保護等道德考量仍然很重要。該市場的特點是激烈的競爭和轉向更個性化的測試策略，為旨在持續成長和市場滲透的公司創造了一個充滿活力但充滿挑戰的環境。

主要市場統計
基準年[2023] 17.4億美元
預測年份 [2024] 18.7億美元
預測年份 [2030] 28.6億美元
複合年成長率（%） 7.28%

市場動態：揭示快速發展的濫用藥物測試市場的關鍵市場洞察

供需的動態交互作用正在改變濫用藥物檢測市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 對藥物濫用治療的需求不斷成長
    • 嚴格的法律要求進行酒精和藥物測試
    • 與毒品相關的死亡率增加和政府的努力
  • 市場限制因素
    • 在一些國家，藥物測試被視為侵犯隱私權
  • 市場機會
    • 介紹創新且使用者友善的一次性產品
    • 藥物檢測技術的進步
  • 市場挑戰
    • 誤報的可能性

波特五力：駕馭藥物濫用測試市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解對濫用藥物測試市場的外部影響

外部宏觀環境因素在塑造濫用藥物測試市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解濫用藥物檢測市場的競爭格局

濫用藥物測試市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣濫用藥物測試市場供應商的績效評估

FPNV 定位矩陣是評估濫用藥物測試市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了濫用藥物測試市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對濫用藥物測試市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對藥物濫用治療的需求增加
      • 嚴格的法律要求進行酒精和藥物測試
      • 毒品相關死亡率上升和政府舉措
    • 抑制因素
      • 在一些國家，藥物測試被認為侵犯隱私權
    • 機會
      • 介紹創新且易於使用的一次性產品
      • 藥物檢測技術進步
    • 任務
      • 假陽性測試的可能性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章濫用藥物測試市場：按組成部分

  • 分析儀
  • 消耗品
  • 化驗服務
  • 快速檢測裝置

第7章按樣本類型分類的濫用藥物檢測市場

  • 血
  • 頭髮
  • 口服補液溶液
  • 汗
  • 尿

第8章濫用藥物測試市場：依最終用戶分類

  • 刑事司法系統與執法
  • 醫院
  • 研究室
  • 職場和學校

第9章美洲濫用藥物測試市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太藥物濫用檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲濫用藥物檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Clinical Reference Laboratory, Inc.
  • Danaher Corporation
  • Drgerwerk AG & Co. KGaA
  • Express Diagnostics International
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare Inc.
  • Laboratory Corporation of America Holdings
  • Legacy Healthcare Services, Inc.
  • Mayo Collaborative Services, Inc.
  • Merck KGaA
  • Pfizer Inc.
  • Precision Diagnostic Services Inc
  • Psychemedics Corporation
  • Quest Diagnostics
  • Sanofi SA
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc
Product Code: MRR-4348D129FA91

The Drug of Abuse Testing Market was valued at USD 1.74 billion in 2023, expected to reach USD 1.87 billion in 2024, and is projected to grow at a CAGR of 7.28%, to USD 2.86 billion by 2030.

The scope of the Drug of Abuse Testing market encompasses the analysis, detection, and monitoring of illegal or prescription drugs in biological samples such as urine, blood, saliva, and hair. This market is defined by the increasing demand for drug screening due to rising substance abuse issues worldwide, underpinning public safety concerns and regulations in workplace, sports, and law enforcement settings. The necessity for drug of abuse testing stems from its critical role in ensuring compliance, promoting a drug-free environment, and mitigating the risks associated with drug misuse. Applications span various sectors including healthcare, corporate, educational institutions, forensic sector, and rehabilitation centers. The industry's growth is driven by factors such as the escalating prevalence of drug addiction, stringent government regulations, and technological advancements in testing methods. Innovations like lab-on-chip, wearables for real-time monitoring, and AI-based analytic tools hold significant potential for market players. However, challenges such as privacy concerns, high costs of advanced drug testing equipment, and variability in regulations across regions can impede growth. Also, the stigma associated with testing and the potential for false-positive results pose significant challenges. For companies aiming at innovation, focusing on developing cost-effective, rapid, and less invasive testing solutions could yield substantial opportunities. Enhancing accuracy and turnaround time using next-generation testing platforms like mass spectrometry and biosensors can also present growth avenues. Furthermore, collaborations with research institutions for developing predictive models for drug abuse prevention can provide a competitive edge. Despite these advancements, maintaining the balance between technological innovation and ethical considerations, such as safeguarding personal data, remains crucial. The market is characterized by intense competition and is shifting towards more personalized testing strategies, creating a dynamic yet challenging landscape for businesses aiming at sustainable growth and market penetration.

KEY MARKET STATISTICS
Base Year [2023] USD 1.74 billion
Estimated Year [2024] USD 1.87 billion
Forecast Year [2030] USD 2.86 billion
CAGR (%) 7.28%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug of Abuse Testing Market

The Drug of Abuse Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for drug abuse treatment
    • Stringent law mandating alcohol and drug testing
    • Increasing drug-related mortality rate and government initiative
  • Market Restraints
    • Drug testing is recognized as a violation of privacy rights in some countries
  • Market Opportunities
    • Introduction to innovative and user-friendly disposable products
    • Technological advancements in drug testing
  • Market Challenges
    • Possibilities of false-positive test

Porter's Five Forces: A Strategic Tool for Navigating the Drug of Abuse Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug of Abuse Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug of Abuse Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug of Abuse Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug of Abuse Testing Market

A detailed market share analysis in the Drug of Abuse Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug of Abuse Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug of Abuse Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug of Abuse Testing Market

A strategic analysis of the Drug of Abuse Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug of Abuse Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bio-Rad Laboratories, Inc., Clinical Reference Laboratory, Inc., Danaher Corporation, Drgerwerk AG & Co. KGaA, Express Diagnostics International, F. Hoffmann-La Roche Ltd, GE Healthcare Inc., Laboratory Corporation of America Holdings, Legacy Healthcare Services, Inc., Mayo Collaborative Services, Inc., Merck KGaA, Pfizer Inc., Precision Diagnostic Services Inc, Psychemedics Corporation, Quest Diagnostics, Sanofi SA, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the Drug of Abuse Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Analyzers, Consumables, Laboratory Services, and Rapid Testing Devices.
  • Based on Sample Type, market is studied across Blood, Hair, Oral Fluids, Sweat, and Urine.
  • Based on End User, market is studied across Criminal Justice Systems & Law Enforcement Agencies, Hospitals, Research Laboratories, and Workplace & School.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for drug abuse treatment
      • 5.1.1.2. Stringent law mandating alcohol and drug testing
      • 5.1.1.3. Increasing drug-related mortality rate and government initiative
    • 5.1.2. Restraints
      • 5.1.2.1. Drug testing is recognized as a violation of privacy rights in some countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction to innovative and user-friendly disposable products
      • 5.1.3.2. Technological advancements in drug testing
    • 5.1.4. Challenges
      • 5.1.4.1. Possibilities of false-positive test
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug of Abuse Testing Market, by Component

  • 6.1. Introduction
  • 6.2. Analyzers
  • 6.3. Consumables
  • 6.4. Laboratory Services
  • 6.5. Rapid Testing Devices

7. Drug of Abuse Testing Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Blood
  • 7.3. Hair
  • 7.4. Oral Fluids
  • 7.5. Sweat
  • 7.6. Urine

8. Drug of Abuse Testing Market, by End User

  • 8.1. Introduction
  • 8.2. Criminal Justice Systems & Law Enforcement Agencies
  • 8.3. Hospitals
  • 8.4. Research Laboratories
  • 8.5. Workplace & School

9. Americas Drug of Abuse Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug of Abuse Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug of Abuse Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Bio-Rad Laboratories, Inc.
  • 3. Clinical Reference Laboratory, Inc.
  • 4. Danaher Corporation
  • 5. Drgerwerk AG & Co. KGaA
  • 6. Express Diagnostics International
  • 7. F. Hoffmann-La Roche Ltd
  • 8. GE Healthcare Inc.
  • 9. Laboratory Corporation of America Holdings
  • 10. Legacy Healthcare Services, Inc.
  • 11. Mayo Collaborative Services, Inc.
  • 12. Merck KGaA
  • 13. Pfizer Inc.
  • 14. Precision Diagnostic Services Inc
  • 15. Psychemedics Corporation
  • 16. Quest Diagnostics
  • 17. Sanofi SA
  • 18. Siemens Healthineers AG
  • 19. Thermo Fisher Scientific Inc

LIST OF FIGURES

  • FIGURE 1. DRUG OF ABUSE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG OF ABUSE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG OF ABUSE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG OF ABUSE TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY WORKPLACE & SCHOOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023